Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The use of recombinant activated factor VII in platelet disorders: a critical review of the literature.

Literature DB >> 19290076

The use of recombinant activated factor VII in platelet disorders: a critical review of the literature.

Massimo Franchini¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2009 PMID： 19290076 PMCID： PMC2652232 DOI： 10.2450/2008.0015-08

Source DB: PubMed Journal: Blood Transfus ISSN： 1723-2007 Impact factor: 3.443

× No keyword cloud information.

39 in total

1. Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated factor VII.

Authors: Benjamin Brenner; Ron Hoffman; Dmitriy Balashov; Elena Shutluko; Sr Dana Culić; Elena Nizamoutdinova
Journal: Clin Appl Thromb Hemost Date: 2005-10 Impact factor: 2.389

Review 2. "Off-license" use of recombinant activated factor VII.

Authors: Sara Ghorashian; Beverley J Hunt
Journal: Blood Rev Date: 2004-12 Impact factor: 8.250

Review 3. Recombinant factor VIIa. An update on its clinical use.

Authors: Massimo Franchini; Marco Zaffanello; Dino Veneri
Journal: Thromb Haemost Date: 2005-06 Impact factor: 5.249

4. Massive pulmonary embolism after treatment with rFVIIa in a thrombocytopenic patient with acute myelogenous leukemia and intractable bleeding.

Authors: George Mantzios; Panagiotis Tsirigotis; Vassiliki Pappa; Konstantina Spirou; Vassiliki Giannopoulou; Irene Kaitsa; Konstantinos Girkas; Efstathios Papageorgiou; John Dervenoulas
Journal: Eur J Haematol Date: 2007-02 Impact factor: 2.997

5. Combination therapy with rFVIIa and platelets for hemorrhage in patients with severe thrombocytopenia and alloimmunization.

Authors: Bipin N Savani; Cynthia E Dunbar; Margaret E Rick
Journal: Am J Hematol Date: 2006-03 Impact factor: 10.047

6. Clinical experience with recombinant factor VIIa in patients with thrombocytopenia.

Authors: J Kristensen; A Killander; E Hippe; C Helleberg; J Ellegard; M Holm; J Kutti; U H Mellqvist; J E Johansson; S Glazer; U Hedner
Journal: Haemostasis Date: 1996

7. Recombinant factor VIIa in severe uremic bleeding.

Authors: T Révész; B Arets; M Bierings; C van den Bos; E Duval
Journal: Thromb Haemost Date: 1998-08 Impact factor: 5.249

8. A patient with Glanzmann thrombasthenia and epistaxis successfully treated with recombinant factor VIIa.

Authors: L Tengborn; B Petruson
Journal: Thromb Haemost Date: 1996-06 Impact factor: 5.249

9. Experiences with recombinant activated factor VII in the treatment of severe refractory thrombocytopenia.

Authors: Grazyna Wróbel; Grzegorz Dobaczewski; Dariusz Patkowski; Agnieszka Sokół; Elzbieta Grotthus
Journal: Pediatr Blood Cancer Date: 2006-10-15 Impact factor: 3.167

10. Use of rFVIIa in 4 children with Glanzmann thrombasthenia.

Authors: Leonard A Valentino
Journal: J Pediatr Hematol Oncol Date: 2006-10 Impact factor: 1.289

6 in total

1. Therapeutic doses of recombinant factor VIIa in hemophilia generates thrombin in platelet-dependent and -independent mechanisms.

Authors: Shiva Keshava; Usha R Pendurthi; Charles T Esmon; L Vijaya Mohan Rao
Journal: J Thromb Haemost Date: 2020-06-25 Impact factor: 5.824

2. Recombinant activated factor VII as an additional agent in the management of bleeding in patients with chemotherapy-induced thrombocytopenia.

Authors: Pavol Hollý; Lenka Lisá; Ivana Plameňová; Miroslava Dobrotová; Peter Kubisz
Journal: Blood Transfus Date: 2012-12-06 Impact factor: 3.443

3. Innovative use of recombinant activated factor VII during physical rehabilitation in an Italian child with Glanzmann's thromboasthenia.

Authors: Paola Giordano; Giuseppe Lassandro; Riccardina Tesse; Stefania Longo; Federica Valente; Anna Rita Cappiello; Antonio Coppola
Journal: Blood Transfus Date: 2012-07-04 Impact factor: 3.443